CAD 0.07
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 984.78 Thousand USD | -63.74% |
2022 | 2.71 Million USD | 51.42% |
2021 | 1.79 Million USD | -70.14% |
2020 | 6 Million USD | 886.98% |
2019 | 608.71 Thousand USD | 306.39% |
2018 | 149.78 Thousand CAD | -26.15% |
2017 | 202.82 Thousand CAD | 76.17% |
2016 | 115.13 Thousand CAD | 58.57% |
2015 | 72.6 Thousand CAD | 40.49% |
2014 | 51.68 Thousand CAD | -12.25% |
2013 | 58.9 Thousand CAD | -18.77% |
2012 | 72.51 Thousand CAD | 527.92% |
2011 | 11.54 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 1.58 Million USD | 9.79% |
2023 Q1 | 1.44 Million USD | -46.87% |
2023 Q4 | 984.78 Thousand USD | -6.9% |
2023 Q3 | 1.05 Million USD | -33.23% |
2022 Q3 | 1.46 Million USD | -6.96% |
2022 Q4 | 2.71 Million USD | 85.12% |
2022 FY | 2.71 Million USD | 51.42% |
2022 Q1 | 2.37 Million USD | 32.15% |
2022 Q2 | 1.57 Million USD | -33.48% |
2021 Q1 | 7.48 Million USD | 24.55% |
2021 Q4 | 1.79 Million USD | -42.96% |
2021 Q3 | 3.14 Million USD | -13.88% |
2021 Q2 | 3.65 Million USD | -51.2% |
2021 FY | 1.79 Million USD | -70.14% |
2020 Q2 | 760.76 Thousand USD | -10.66% |
2020 FY | 6 Million USD | 886.98% |
2020 Q4 | 6 Million USD | 864.92% |
2020 Q3 | 622.63 Thousand USD | -18.16% |
2020 Q1 | 851.55 Thousand USD | 39.89% |
2019 Q2 | 275.39 Thousand CAD | 29.58% |
2019 Q1 | 212.52 Thousand CAD | 41.89% |
2019 FY | 608.71 Thousand USD | 306.39% |
2019 Q4 | 608.71 Thousand USD | 75.17% |
2019 Q3 | 347.5 Thousand CAD | 26.18% |
2018 Q2 | 15.96 Thousand CAD | -92.66% |
2018 FY | 149.78 Thousand CAD | -26.15% |
2018 Q4 | 149.78 Thousand CAD | 2184.69% |
2018 Q3 | 6556.02 CAD | -58.94% |
2018 Q1 | 217.66 Thousand CAD | 7.31% |
2017 Q3 | 178.16 Thousand CAD | 12.31% |
2017 Q2 | 158.63 Thousand CAD | 12.11% |
2017 Q1 | 141.49 Thousand CAD | 22.9% |
2017 FY | 202.82 Thousand CAD | 76.17% |
2017 Q4 | 202.82 Thousand CAD | 13.84% |
2016 FY | 115.13 Thousand CAD | 58.57% |
2016 Q1 | 81.04 Thousand CAD | 11.62% |
2016 Q3 | 105 Thousand CAD | 16.24% |
2016 Q2 | 90.33 Thousand CAD | 11.46% |
2016 Q4 | 115.13 Thousand CAD | 9.65% |
2015 Q1 | 53.72 Thousand CAD | 3.95% |
2015 FY | 72.6 Thousand CAD | 40.49% |
2015 Q4 | 72.6 Thousand CAD | 14.05% |
2015 Q3 | 63.66 Thousand CAD | 7.79% |
2015 Q2 | 59.06 Thousand CAD | 9.93% |
2014 Q1 | 58.76 Thousand CAD | -0.23% |
2014 Q3 | 47.54 Thousand CAD | -6.21% |
2014 Q2 | 50.68 Thousand CAD | -13.75% |
2014 Q4 | 51.68 Thousand CAD | 8.71% |
2014 FY | 51.68 Thousand CAD | -12.25% |
2013 FY | 58.9 Thousand CAD | -18.77% |
2013 Q4 | 58.9 Thousand CAD | 8.27% |
2013 Q1 | 72.42 Thousand CAD | -0.12% |
2013 Q2 | 57.25 Thousand CAD | -20.95% |
2013 Q3 | 54.4 Thousand CAD | -4.98% |
2012 Q3 | 48.99 Thousand CAD | 13.23% |
2012 FY | 72.51 Thousand CAD | 527.92% |
2012 Q2 | 43.27 Thousand CAD | 31.48% |
2012 Q1 | 32.91 Thousand CAD | 184.99% |
2012 Q4 | 72.51 Thousand CAD | 47.99% |
2011 FY | 11.54 Thousand CAD | 0.0% |
2011 Q4 | 11.54 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | 66.464% |
Ayurcann Holdings Corp. | 14.31 Million CAD | 93.123% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -109.206% |
The BC Bud Corporation | 626 Thousand CAD | -57.313% |
BioNxt Solutions Inc. | 6.55 Million CAD | 84.966% |
CordovaCann Corp. | 11.29 Million CAD | 91.278% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | 88.416% |
Captor Capital Corp. | 28.76 Million CAD | 96.576% |
City View Green Holdings Inc. | 3.73 Million CAD | 73.619% |
1CM Inc. | 9.42 Million CAD | 89.55% |
Global Hemp Group Inc. | 5.82 Million CAD | 83.094% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 95.349% |
IM Cannabis Corp. | 35.11 Million CAD | 97.195% |
Lobe Sciences Ltd. | 2.45 Million CAD | 59.962% |
Maple Leaf Green World Inc. | 10.08 Million CAD | 90.231% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -281.699% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | 77.636% |
Ovation Science Inc. | 728.99 Thousand CAD | -35.088% |
Pharmadrug Inc. | 2.92 Million CAD | 66.338% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | 52.858% |
RAMM Pharma Corp. | 2.83 Million CAD | 65.27% |
RIV Capital Inc. | 275.63 Million CAD | 99.643% |
Revive Therapeutics Ltd. | 3.4 Million CAD | 71.069% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.73% |
SLANG Worldwide Inc. | 37.58 Million CAD | 97.38% |
1933 Industries Inc. | 23.28 Million CAD | 95.77% |
Red Light Holland Corp. | 3.82 Million CAD | 74.232% |
Top Strike Resources Corp. | 20.99 Million CAD | 95.309% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -24.663% |
Adastra Holdings Ltd. | 17.65 Million CAD | 94.423% |